Business Standard

Tuesday, January 28, 2025 | 05:15 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Astrazeneca to begin Phase 1/2 clinical trials of Covid vaccine in Japan

Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate

AstraZeneca logo. Photo: Twitter

AstraZeneca logo. Photo: Twitter

Reuters TOKYO

TOKYO (Reuters) - Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate.

Trials of the vaccine, known as AZD1222, will be conducted at multiple facilities in Japan, targeting 250 subjects, the company said in a release.

The British company is working with Daiichi Sankyo, JCR Pharma and other partners in Japan to make and distribute the vaccine.

 

(Reporting by Rocky Swift and Chris Gallagher in Tokyo; Editing by Tom Hogue)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 04 2020 | 1:10 PM IST

Explore News